128 related articles for article (PubMed ID: 21292869)
1. Quantitative assessment of tumor blood flow in mice after treatment with different doses of an antiangiogenic agent with contrast-enhanced destruction-replenishment US.
Zhou JH; Cao LH; Liu JB; Zheng W; Liu M; Luo RZ; Han F; Li AH
Radiology; 2011 May; 259(2):406-13. PubMed ID: 21292869
[TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced ultrasonic parametric perfusion imaging in the evaluation of antiangiogenic tumor treatment.
Zhou JH; Zheng W; Cao LH; Liu M; Luo RZ; Han F; Wu PH; Li AH
Eur J Radiol; 2012 Jun; 81(6):1360-5. PubMed ID: 21345633
[TBL] [Abstract][Full Text] [Related]
3. Quantitative evaluation of viable tissue perfusion changes with contrast-enhanced greyscale ultrasound in a mouse hepatoma model following treatment with different doses of thalidomide.
Zhou JH; Zheng W; Cao LH; Liu M; Luo RZ; Han F; Wu PH; Li AH
Br J Radiol; 2011 Sep; 84(1005):826-32. PubMed ID: 21224299
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic tumor treatment: noninvasive monitoring with contrast pulse sequence imaging for contrast-enhanced grayscale ultrasound.
Zhou J; Zheng W; Cao L; Liu M; Han F; Li A
Acad Radiol; 2010 May; 17(5):646-51. PubMed ID: 20223684
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive contrast-enhanced US quantitative assessment of tumor microcirculation in a murine model: effect of discontinuing anti-VEGF therapy.
Guibal A; Taillade L; Mulé S; Comperat E; Badachi Y; Golmard JL; Le Guillou-Buffello D; Rixe O; Bridal SL; Lucidarme O
Radiology; 2010 Feb; 254(2):420-9. PubMed ID: 20093514
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis inhibitors in a murine neuroblastoma model: quantitative assessment of intratumoral blood flow with contrast-enhanced gray-scale US.
McCarville MB; Streck CJ; Dickson PV; Li CS; Nathwani AC; Davidoff AM
Radiology; 2006 Jul; 240(1):73-81. PubMed ID: 16793972
[TBL] [Abstract][Full Text] [Related]
7. Intra-Animal Comparison between Three-dimensional Molecularly Targeted US and Three-dimensional Dynamic Contrast-enhanced US for Early Antiangiogenic Treatment Assessment in Colon Cancer.
Wang H; Lutz AM; Hristov D; Tian L; Willmann JK
Radiology; 2017 Feb; 282(2):443-452. PubMed ID: 27490690
[TBL] [Abstract][Full Text] [Related]
8. Stress Test of Contrast-Enhanced US with Phenylephrine in a Rabbit VX2 Liver Tumor Model: Differentiating Benign Periablational Enhancement from Residual Tumor after Radiofrequency Ablation.
Kan X; Zhang Y; Zheng C; Li L; Chen J; Wu Y; Guo T; Xiong B
J Vasc Interv Radiol; 2016 Jul; 27(7):1077-1085.e2. PubMed ID: 27117950
[TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced gray-scale ultrasound for quantitative evaluation of tumor response to chemotherapy: preliminary results with a mouse hepatoma model.
Zhou JH; Cao LH; Zheng W; Liu M; Han F; Li AH
AJR Am J Roentgenol; 2011 Jan; 196(1):W13-7. PubMed ID: 21178025
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis: noninvasive quantitative assessment with contrast-enhanced functional US in murine model.
Lucidarme O; Kono Y; Corbeil J; Choi SH; Golmard JL; Varner J; Mattrey RF
Radiology; 2006 Jun; 239(3):730-9. PubMed ID: 16714458
[TBL] [Abstract][Full Text] [Related]
11. Comparison of tumor vascularity and hemodynamics in three rat hepatoma models.
Choi JW; Kim JH; Kim HC; Choi WS; Baek SY; Lee K; Chung JW
Abdom Radiol (NY); 2016 Feb; 41(2):257-64. PubMed ID: 26867907
[TBL] [Abstract][Full Text] [Related]
12. [Effect of thalidomide on tumor growth in mouse hepatoma H22 model].
Zhai Y; Lu ZJ
Ai Zheng; 2003 Dec; 22(12):1301-6. PubMed ID: 14693056
[TBL] [Abstract][Full Text] [Related]
13. Advanced hepatocellular carcinoma: early evaluation of response to bevacizumab therapy at dynamic contrast-enhanced US with quantification--preliminary results.
Lassau N; Koscielny S; Chami L; Chebil M; Benatsou B; Roche A; Ducreux M; Malka D; Boige V
Radiology; 2011 Jan; 258(1):291-300. PubMed ID: 20980447
[TBL] [Abstract][Full Text] [Related]
14. Blood flow changes in hepatocellular carcinoma after the administration of thalidomide assessed by reperfusion kinetics during microbubble infusion: preliminary results.
Bertolotto M; Pozzato G; Crocè LS; Nascimben F; Gasparini C; Cova MA; Tiribelli C
Invest Radiol; 2006 Jan; 41(1):15-21. PubMed ID: 16355035
[TBL] [Abstract][Full Text] [Related]
15. Effect of an angiogenesis inhibitor on hepatic tumor perfusion and the implications for adjuvant cytotoxic therapy.
Stewart EE; Sun H; Chen X; Schafer PH; Chen Y; Garcia BM; Lee TY
Radiology; 2012 Jul; 264(1):68-77. PubMed ID: 22627603
[TBL] [Abstract][Full Text] [Related]
16. Effect of thalidomide in hepatocellular carcinoma: assessment with power doppler US and analysis of circulating angiogenic factors.
Hsu C; Chen CN; Chen LT; Wu CY; Hsieh FJ; Cheng AL
Radiology; 2005 May; 235(2):509-16. PubMed ID: 15858091
[TBL] [Abstract][Full Text] [Related]
17. Three-dimensional Dynamic Contrast-enhanced US Imaging for Early Antiangiogenic Treatment Assessment in a Mouse Colon Cancer Model.
Wang H; Hristov D; Qin J; Tian L; Willmann JK
Radiology; 2015 Nov; 277(2):424-34. PubMed ID: 26020439
[TBL] [Abstract][Full Text] [Related]
18. Correlation of contrast-enhanced ultrasound with two distinct types of blood vessels for the assessment of angiogenesis in lewis lung carcinoma.
Zhuo J; Fu W; Liu S
Ultraschall Med; 2014 Oct; 35(5):468-72. PubMed ID: 24327471
[TBL] [Abstract][Full Text] [Related]
19. Quantitative contrast-enhanced ultrasound for imaging antiangiogenic treatment response in experimental osteolytic breast cancer bone metastases.
Merz M; Komljenovic D; Semmler W; Bäuerle T
Invest Radiol; 2012 Jul; 47(7):422-9. PubMed ID: 22659593
[TBL] [Abstract][Full Text] [Related]
20. Contrast-enhanced Ultrasound Imaging of Antiangiogenic Tumor Therapy.
Klotz LV; Clevert DA; Scheckinger S; Strieth S; Eichhorn ME
Anticancer Res; 2015 May; 35(5):2571-6. PubMed ID: 25964532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
